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Abstract: 
Biobanks are essential tools in diagnostics and therapeutics research and development related to personalized medicine. Several 
international recommendations, standards and guidelines exist that discuss the legal, ethical, technological, and management 
requirements of biobanks. Today’s biobanks are much more than just collections of biospecimens. They also store a huge amount of 
data related to biological samples which can be either clinical data or data coming from biochemical experiments. A well-designed 
biobank software system also provides the possibility of finding associations between stored elements. Modern research biobanks 
are able to manage multicenter sample collections while fulfilling all requirements of data protection and security. While 
developing several biobanks and analyzing the data stored in them, our research group recognized the need for a well-organized, 
easy-to-check requirements guideline that can be used to develop biobank software systems. International best practices along with 
relevant ICT standards were integrated into a comprehensive guideline: The Model Requirements for the Management of Biological 
Repositories (BioReq), which covers the full range of activities related to biobank development. The guideline is freely available on 
the Internet for the research community. 
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Background: 
Research biobanks are among the most indispensable tools in 
the era of personalized medicine. A decade ago, biobanks were 
just simply repositories of biospecimens. Clinical data of limited 
quantity and quality had to be retrieved from hospital 
information systems retrospectively. 
 
This trend has significantly changed recently. The number of 
patients involved in projects increased, sample and data 
collection has also become multicentred. Molecular biological 
experiments based on high-throughput technologies (e.g. 
microarray, Next Generation Sequencing) serve as primary 
sources of the increasing amount of data. Consequently, 
biobanks store huge amounts of data of different origin that 
need to be managed and analyzed by combining them with 
each other while supporting scientific needs. Besides data 
protection and security, the legal and ethical regulation of 
patients’ rights also receives more pronounced attention. All 
this amounts to a strong need for a biobank software system 
supporting data collection, management and analysis. 
 
The fact that most research biobanks are disease and project-
specific makes it unfeasible to develop standard software 
systems solutions. Biobank projects differ in study design, 
applied methods of data collection and analysis in terms of 
collected biospecimens, personal and health information (e.g. 
health records, family history, lifestyle and genetic 
information). These differences are demonstrated by comparing BIOINFORMATION  open access 
 
ISSN 0973-2063 (online) 0973-8894 (print)     
Bioinformation 8(6): 290-292 (2012)  291   © 2012 Biomedical Informatics
 
the clinical data content of three biobanks developed by the 
research team. (Figure 1) illustrates the results, showing that 
there is little overlap between the clinical data features stored in 
them. According to this comparison, as many as 500 features 
are stored in the three biobanks but the center overlap between 
them is just 5%, which means approximately 25 features [1-3]; 
the majority of the matching data originate from blood samples. 
The significant diversity of the 95% of features can be explained 
by the project-specific nature of diagnostics and therapeutics 
research required for specified questionnaires. In spite of the 
variety of biobanks mentioned above, there are standards and 
regulations that should be taken into consideration during the 
development of a biobank software system, like data protection 
and security. Other aspects should also be considered during 
the development process. 
 
 
Figure 1: A Venn diagram showing the intersection of features 
represented in SCHIZO (schizophrenia patients), HPV (HPV-
infected human tissue), and Trisomy (numerical chromosomal 
aberrations) Biobanks (numbers refer to clinical data per 
patient) 
 
Methodology: 
The objective of the work was to prepare a comprehensive 
guideline,  Model Requirements for the Management of Biological 
Repositories  (BioReq) covering ethical, technical, management, 
and ICT requirements applicable to the development of biobank 
software systems. The guideline also references the best-known 
international standards and recommendations, such as Best 
Practices for Repositories I: Collection, Storage, and Retrieval of 
Human Biological Materials for Research or OECD Best Practice 
Guidelines for Biological Resource Centers [4, 5]. Its novelty is 
the well-structured and precise collection of ICT requirements, 
which can be a practical help for research groups with little 
experience in the field of biobank software system 
development. 
 
The first version of BioReq was finished in 2011. In the same 
year, using this guideline, our research group developed a new 
biobank software system. The project proved the feasibility of 
the guideline, and its success served as a further motivation for 
developing and releasing version 2.0. 
 
The guideline consists of four chapters: (1) Ethical 
Requirements; (2) Technical Requirements; (3) Management 
Requirements; and (4) Biobank Software System Requirements. 
Each chapter is divided into sections containing the 
requirements presented in a table format. In this way, the 
guideline is a collection of carefully organized, easy-to-check 
requirements as opposed to other standards, where the 
recommendations are provided in the form of unstructured 
narrative paragraphs. During the guideline preparation, 
internationally-accepted recommendations and standards have 
been considered that were judged as applicable to research-
purpose biorepositories. Since the various standards show a 
significant overlap in scope, repetitions have been removed, 
and conflicting requirements have been resolved. While 
preparing  BioReq, we have adapted the requirements of 
MoReq2 [6] (a joint European specification of electronic records 
management) to serve the needs of biobanks. 
 
The content of the first three chapters have been analyzed and 
translated into software system requirements so that the 
Biobank Software System (BSS) Requirements part (chapter 4) 
can be used on its own for design purposes. 
 
 
Figure 2: Biological sample life cycle processes 
 
BSS Requirements: 
The BSS Requirements (last chapter of the guideline) chapter 
first covers metadata requirements [7] and the outline of entity BIOINFORMATION  open access 
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types managed by a BSS [8, 9], then discusses general sample-
related processes requirements [10].The flow chart displayed on 
(Figure 2) presents the biological sample lifecycle processes 
from sample acquisition through sample and data management 
to sample destruction and distribution. Depending on the size 
and needs of the operating organization, the BSS may be 
required to track laboratory processes. 
 
BBS contains purely technical requirements not strictly related 
to biobank-specific processes (e.g. user management, search, 
logging), and supports biobank audits with features to monitor 
the system and provide a number of standard reports capable of 
being configured by authorized users. Non-functional 
requirements contributing to security, usability, performance, 
and scalability are also important attributes of a successful BSS 
implementation. External interface requirements specify the 
characteristics of the system’s interaction with the hardware 
platform and with other software components outside the 
boundary of the BSS and they provide guidance on user 
interface design consideration as well. 
 
Conclusion: 
I n  t h i s  p a p e r  w e  h a v e  g i v e n  a n  o v e r v i e w  o f  t h e  Model 
Requirements for the Management of Biological Repositories 
guideline. We have shown that the guideline successfully 
incorporates the best practices of international standards on 
biobanks, giving users a single and consistent document to 
review. The novelty of the guideline lies (1) in its 
comprehensive coverage of topics from legal regulations to ICT 
considerations, and (2) in the strict format used in describing 
the requirements, which can guide implementation and can 
serve as a feature checklist. Note however that for any specific 
biobank software system care must be taken to adhere to all 
national regulations; this lies outside the scope of BioReq. Based 
on the presented content, the Model Requirements for the 
Management of Biological Repositories guideline provides a 
comprehensive aid in operating biobanks and conducting 
research involving biospecimens. 
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